Antiviral treatment is prescribed for HBeAg-negative hepatitis patients with viral DNA levels >10,000 copies/mL and either a twofold increase in ALT and/or histologic activity (>A2) or fibrosis (>F2) [24,25]. The gene discussed is GPT; the disease is Hepatitis.